Search
for
Sort by
Research 181–210 of 1000+
- Dimensions of drug information
- The adverse effects of commonly used medications on male fertility: a comprehensive review
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- MODIFICATION OF PINEAPPLE FIBER AND APPLICATION IN DRUG DELIVERY
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Adverse effects of voriconazole: Over a decade of use
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Blood Donors on Medication – an Approach to Minimize Drug Burden for Recipients of Blood Products and to Limit Deferral of Donors
- Physical methods for topical skin drug delivery: concepts and applications
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Chronic Arsenicism: Criminal Poisoning or Drug-Intoxication?
- Cerebral Venous Sinus Thrombosis Associated with Dutasteride Use
- Combining rapid degrading microneedles with Slow-Released drug delivery system for the treatment of alopecia areata
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- Acute central serous chorioretinopathy following topical minoxidil use for androgenic alopecia - A case report
- 1P-230: Synthesis and in vitro characterization of 68 Ga labeled Fe 3 O 4 nanoparticles for drug delivery
- Signaling pathways in the mechanisms of drug action
- Progress in Lipid and Inorganic Nanocarriers for Enhanced Skin Drug Delivery
- Formulation of Sodium Valproate Nanospanlastics as a Promising Approach for Drug Repurposing in the Treatment of Androgenic Alopecia
- A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems
- Changes in Minoxidil Prescribing After Media Attention About Oral Use for Hair Loss
- Case report of Esophagus Squamous Cell Carcinoma treated with Novel Drug Preparation Method of Catheranthus rosea (Periwinkle) - An Integrated Oncological approach
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development
- Exhaustive analysis of scalp hair regression: subjective and objective perception from initial hair loss to severe miniaturisation and drug-induced regrowth
- An Unusual Case of Thalamic Stroke in a Young Adult With Patent Foramen Ovale and Finasteride Use